Stiefel Laboratories Implements Medidata Rave(R) to Achieve Immediate Cost Savings across Global Clinical Studies

NEW YORK--(BUSINESS WIRE)--Medidata Solutions, a leading provider of clinical trial solutions, today announced that Stiefel Laboratories has selected Medidata Rave® as the central component of its clinical data management process. Medidata Rave has already helped Stiefel to significantly reduce upfront study costs and expanded use of this electronic data capture (EDC), management and reporting solution is expected to play a key role in helping Stiefel to achieve a projected 35 percent reduction in data management costs during the next three years.

MORE ON THIS TOPIC